mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.0047 |
0.9 |